These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 14981990)
1. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990 [TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer. Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759 [TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases. Neyns B; Van Nieuwenhove Y; Aerts M; Fontaine C; Vermeij J; Schallier D; Decoster L; De Mey J; Vandenbroucke F; Hoorens A; Delvaux G; De Gréve J Anticancer Res; 2006; 26(1B):611-9. PubMed ID: 16739329 [TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M; J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952 [TBL] [Abstract][Full Text] [Related]
5. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089 [TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145 [TBL] [Abstract][Full Text] [Related]
7. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases. Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response. Kern W; Beckert B; Lang N; Waggershauser T; Braess J; Schalhorn A; Hiddemann W Anticancer Res; 2000; 20(6D):4973-5. PubMed ID: 11326650 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914 [TBL] [Abstract][Full Text] [Related]
10. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373 [TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer. Seki H; Ozaki T; Shiina M Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157 [TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer. Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer. Chiara S; Nobile MT; Gozza A; Taveggia P; Heouaine A; Pastrone I; Percivale PL; Lionetto R; Sanguineti O; Rosso R Anticancer Res; 2004; 24(1):355-60. PubMed ID: 15015621 [TBL] [Abstract][Full Text] [Related]
14. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC). Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625 [TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study. Fiorentini G; Rossi S; Dentico P; Meucci F; Bonechi F; Bernardeschi P; Cantore M; Guadagni S; De Simone M Anticancer Res; 2004; 24(3b):2093-6. PubMed ID: 15274406 [TBL] [Abstract][Full Text] [Related]
16. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259 [TBL] [Abstract][Full Text] [Related]
17. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973). Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865 [TBL] [Abstract][Full Text] [Related]
18. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708 [TBL] [Abstract][Full Text] [Related]
19. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433 [TBL] [Abstract][Full Text] [Related]
20. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. Neyns B; Aerts M; Van Nieuwenhove Y; Fontaine C; De Coster L; Schallier D; Vanderauwera J; De Munck F; Vandenbroucke F; Everaert H; Meert V; De Mey J; De Ridder M; Delvaux G; De Grève J Anticancer Res; 2008; 28(4C):2459-67. PubMed ID: 18751435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]